To Determine Safety, Tolerability and Efficacy of ONCOS-102 in Combination With Chemotherapy

Clinical trial pipeline · Data from ClinicalTrials.gov

See which To Determine Safety, Tolerability and Efficacy of ONCOS-102 in Combination With Chemotherapy trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

UnknownPhase 1/2

NCT02879669

A Randomised Phase II Open-label Study With a Phase Ib Safety lead-in Cohort of ONCOS-102, an Immune-priming GM-CSF Codi…

The trial is an open-label, parallel group, multicentre trial that will recruit a total of 30 patients with malignant pleural mesothelioma. The trial will be co…

France, Spain31 participantsStarted 2016-06

Treatment: ONCOS-102, Pemetrexed/cisplatin (carboplatin)